VBI Vaccines @VBIVaccines (Nasdaq: $VBIV) (TSX: $VBV) Provides Update on its Congenital #CMV Phase I Clinical Study
Positive Safety Review and Final Vaccination of All Participants
CAMBRIDGE, MA (May 2, 2017) – (Investorideas.com Newswire) VBI Vaccines Inc. (Nasdaq: VBIV) ( ... Read more